1
Clinical Trials associated with Autologous total tumor mRNA loaded DOTAP liposome vaccine(University of Florida)Novel RNA-nanoparticle Vaccine for the Treatment of Early Melanoma Recurrence Following Adjuvant Anti-PD-1 Antibody Therapy
The goal of this phase I trial is to evaluate the toxicity and feasibility of a tumor-specific RNA-NP vaccine in patients with stage IIB-IV melanoma who have progressed on anti-PD1 (a-PD1) adjuvant therapy.
100 Clinical Results associated with Autologous total tumor mRNA loaded DOTAP liposome vaccine(University of Florida)
100 Translational Medicine associated with Autologous total tumor mRNA loaded DOTAP liposome vaccine(University of Florida)
100 Patents (Medical) associated with Autologous total tumor mRNA loaded DOTAP liposome vaccine(University of Florida)
100 Deals associated with Autologous total tumor mRNA loaded DOTAP liposome vaccine(University of Florida)